Meihua Biotech advances share repurchase and completes overseas asset acquisition

Meihua Holdings Group (SSE:600873) announced significant progress in its share repurchase program and the completion of a key overseas asset acquisition. As of June 2025, the company has repurchased 35,708,400 shares, representing 1.25% of its total share capital, at prices ranging from CNY 9.10 to CNY 10.68 per share, for a total expenditure of CNY 352,024,400 excluding transaction costs. These repurchased shares are intended for cancellation to reduce registered capital.